Please assess the completion status of the following clinical trial:

Trial Title: Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Ability to implant device less than 12 weeks post-SCI~* Presence of acute SCI at or above T12~* ASIA Scale A or B~* Expectation to perform CIC personally or have caretaker perform CIC~Exclusion Criteria:~* Inability to perform CIC~* Pre-existing SCI~* Pre-existing progressive neurological disorder~* Autonomic dysreflexia~* Prior sacral back surgery~* Posterior pelvic fracture with distortion of the sacroiliac joint~* Prior urethral sphincter or bladder dysfunction~* Chronic urinary tract infections prior to SCI~* Pregnancy at the time of enrollment~* Presence of coagulation disorder or need for anticoagulation that they cannot be stopped temporarily for procedure~* Any significant co-morbidity or illness that would preclude their participation or increase the risk to them having a surgical procedure~* Active untreated infection~* Traumatic injury to the genitourinary system~* Prior pelvic radiation, bladder cancer or other surgical procedure to the bladder that would effect baseline bladder physiology

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sacral neuromodulation (Type: EXPERIMENTAL): Bilateral sacral neuromodulation will start within 3 months of spinal cord injury, as well as standard neurogenic bladder care.
- Standard care (Type: NO_INTERVENTION): Patients will receive standard neurogenic bladder care.

Based on this trial design, predict the completion outcome and termination type (if applicable).